{
    "NCT05508789": {
        "inclusion_criteria_match": [
            "0",
            "10"
        ],
        "exclusion_criteria_match": [
            "0"
        ],
        "relevance_explanation": "The patient's note indicates progressive memory loss and cognitive deficits, which are relevant to the study's focus on early Alzheimer's disease. The patient also has severe cognitive deficits and memory dysfunction, which aligns with the MMSE score requirement. However, there is no mention of the required MMSE score range or specific imaging scan criteria.",
        "relevance_score_R": 70,
        "eligibility_explanation": "The patient's history of progressive memory loss and severe cognitive deficits suggests eligibility for the study. However, the note does not provide specific details about the MMSE score or the required imaging scans, which are critical inclusion criteria. The mention of jerking movements and EEG findings suggest other neurological issues that could disqualify the patient based on the exclusion criteria.",
        "eligibility_score_E": -70
    },
    "NCT05026866": {
        "inclusion_criteria_match": [
            "No match"
        ],
        "exclusion_criteria_match": [
            "0",
            "1",
            "2",
            "3",
            "4",
            "5",
            "6",
            "7",
            "8",
            "9",
            "10"
        ],
        "relevance_explanation": "The patient's note indicates severe cognitive deficits and memory dysfunction, which are indicative of a more advanced stage of cognitive impairment. The neuroimaging and biopsy findings suggest a diagnosis more consistent with advanced neurodegenerative disease rather than preclinical Alzheimer's Disease. The patient also shows jerking movements of the lower extremities, which could indicate other neurological conditions.",
        "relevance_score_R": 10,
        "eligibility_explanation": "The patient's severe cognitive deficits and advanced neurodegenerative symptoms disqualify them from the trial, which is designed for participants with preclinical Alzheimer's Disease. Additionally, the patient's advanced disease stage and other neurological symptoms are not consistent with the inclusion criteria for this trial.",
        "eligibility_score_E": -10
    },
    "NCT06297590": {
        "inclusion_criteria_match": [
            "1",
            "2",
            "3",
            "4"
        ],
        "exclusion_criteria_match": [
            "0"
        ],
        "relevance_explanation": "The patient's note indicates progressive memory loss and cognitive deficits, which are consistent with early symptomatic Alzheimer's Disease. The patient also shows compliance with the trial protocol, which is a positive aspect for participation.",
        "relevance_score_R": 85,
        "eligibility_explanation": "While the patient shows symptoms consistent with early symptomatic Alzheimer's Disease and demonstrates compliance, the note does not provide specific information about the patient's BMI, MMSE score, CDR global score, or flortaucipir F18 PET criteria. Additionally, the patient has severe cognitive deficits and memory dysfunction, which could indicate serious or unstable illnesses that might interfere with the study.",
        "eligibility_score_E": 50
    },
    "NCT06653153": {
        "inclusion_criteria_match": [
            "3",
            "5"
        ],
        "exclusion_criteria_match": [
            "1",
            "0"
        ],
        "relevance_explanation": "The patient's note indicates severe cognitive deficits and memory dysfunction, which are relevant to the study of early Alzheimer's disease. The patient also shows compliance with the trial protocol, which is important for the study.",
        "relevance_score_R": 70,
        "eligibility_explanation": "The patient has severe cognitive deficits, which likely excludes them from the inclusion criteria that require no to minimal cognitive impairment. Additionally, the mention of severe cognitive deficits and memory dysfunction aligns with the exclusion criteria for dementia or significant neurological disease.",
        "eligibility_score_E": -70
    },
    "NCT06566170": {
        "inclusion_criteria_match": [
            "2",
            "4"
        ],
        "exclusion_criteria_match": [],
        "relevance_explanation": "The patient's note indicates progressive memory loss and severe cognitive deficits, which are relevant to the study of early symptomatic Alzheimer's Disease. The patient also has a reliable study partner and consents to the trial protocol.",
        "relevance_score_R": 80,
        "eligibility_explanation": "The patient does not meet the exclusion criteria and meets several inclusion criteria, such as having a reliable study partner and willingness to comply with the trial protocol. However, the patient's severe cognitive deficits and advanced cerebral atrophy suggest a more advanced stage of the disease, which may not fit the 'early symptomatic' criteria.",
        "eligibility_score_E": 60
    },
    "NCT06538116": {
        "inclusion_criteria_match": [
            "0",
            "1",
            "3",
            "4"
        ],
        "exclusion_criteria_match": [
            "0"
        ],
        "relevance_explanation": "The patient's note indicates a diagnosis consistent with Alzheimer's Disease, including progressive memory loss, cognitive deficits, and cerebral atrophy. The patient also has a reliable study partner who can provide consent and comply with the trial protocol.",
        "relevance_score_R": 85,
        "eligibility_explanation": "The patient meets several inclusion criteria but is excluded due to being of childbearing potential. The progressive memory loss and cognitive deficits are consistent with mild to moderate Alzheimer's Disease, but the exclusion criterion related to childbearing potential disqualifies the patient.",
        "eligibility_score_E": 42
    },
    "NCT06809400": {
        "inclusion_criteria_match": [
            "9",
            "10",
            "11"
        ],
        "exclusion_criteria_match": [
            "1",
            "2",
            "3",
            "4",
            "5",
            "6",
            "7",
            "8",
            "9",
            "10"
        ],
        "relevance_explanation": "The patient's note indicates a diagnosis of Parkinson's disease and cognitive deficits, which aligns with some inclusion criteria for participants with Parkinson's disease. However, the patient's age and symptoms also suggest significant neurological issues that could disqualify them from the trial.",
        "relevance_score_R": 40,
        "eligibility_explanation": "The patient meets some inclusion criteria for having Parkinson's disease and cognitive assessment, but also meets several exclusion criteria due to significant neurological diseases and potential allergies or unstable conditions. Given these factors, the patient is unlikely to be eligible for the trial.",
        "eligibility_score_E": -40
    },
    "NCT06657768": {
        "inclusion_criteria_match": [
            "sentence id 5"
        ],
        "exclusion_criteria_match": [],
        "relevance_explanation": "The patient's note indicates that the patient has progressive memory loss, cognitive deficits, and other symptoms that are consistent with early symptomatic Alzheimer's Disease (AD). The patient also shows compliance with trial protocols, which is a positive aspect for participation.",
        "relevance_score_R": 85,
        "eligibility_explanation": "The patient's symptoms and neuroimaging findings are consistent with early symptomatic Alzheimer's Disease, which is a target inclusion criterion for Part B of the study. However, the patient's age and the absence of explicit mention of early symptomatic AD in the note make the eligibility less straightforward. The patient does not have any explicit exclusion criteria mentioned.",
        "eligibility_score_E": 70
    },
    "NCT06220669": {
        "inclusion_criteria_match": [
            "5"
        ],
        "exclusion_criteria_match": [],
        "relevance_explanation": "The patient's note mentions relapsing-remitting multiple sclerosis (RRMS) and an EDSS score \u2264 5.5, which aligns with the inclusion criteria for the clinical trial. However, the note does not provide information on relapses or active GdE brain lesions.",
        "relevance_score_R": 40,
        "eligibility_explanation": "The patient has relapsing-remitting multiple sclerosis and an EDSS score \u2264 5.5, which meets the inclusion criteria. However, there is no information on recent relapses or active GdE brain lesions, which are also required for inclusion. The exclusion criteria are not met based on the provided information.",
        "eligibility_score_E": 40
    },
    "NCT06719128": {
        "inclusion_criteria_match": [
            "4"
        ],
        "exclusion_criteria_match": [
            "6",
            "7",
            "10",
            "11"
        ],
        "relevance_explanation": "The patient's note mentions a diagnosis of cerebral atrophy and severe cognitive deficits, which are neurological conditions. However, the patient also indicates compliance with the trial protocol, which is a positive inclusion criterion.",
        "relevance_score_R": 40,
        "eligibility_explanation": "The patient has a neurological condition that would exclude them from the trial due to the exclusion criteria. However, they are compliant with the trial protocol, which is a positive inclusion criterion. Given the severe neurological condition, the eligibility score is lower than the relevance score.",
        "eligibility_score_E": 20
    }
}